Although all the above presented results strongly suggest that double deletion of Pten and p53 causes the development of UCS, we could not rule out the possibility that TAT‐Cre ablation of Pten and p53 observed in stromal cells could lead to development of uterine sarcomas. The gene discussed is TP53; the disease is uterine corpus sarcoma.